Хэл Страус: Я ненавижу тебя, только не бросай меня. Пограничные личности и как их понять

Marsha M. Linehan, Cognitive-Behavioral Treatment of Borderline Personality Disorder (New York: Guilford, 2003).

Nancee Blum, Bruce Pfohl, Don St. John, et al., “STEPPS: A Cognitive – Behavioral Systems-Based Group Treatment for Outpatients with Borderline Personality Disorder – A Preliminary Report,” Comprehensive Psychiatry 43 (2002): 301–310.

Лестница ( англ .). Расшифровывается следующим образом: Постановка целей (Setting goals), Доверие (Trusting), Управление гневом (Anger management), Контроль импульсивности (Impulsivity control), Поведение в отношениях (Relationship behavior), Написание сценария (Writing a script), Тренировка уверенности в себе (Assertiveness training), Твой путь (Your journey), Пересмотр схем (Schemas revisiting). – Примеч. пер .

Jeffrey E. Young, Janet S. Klosko, Marjorie E. Weishaar, Schema Therapy: A Practitioner’s Guide (New York: Guilford, 2003).

Peter Fonagy, “Thinking About Thinking: Some Clinical and Theoretical Considerations in the Treatment of a Borderline Patient,” International Journal of Psychoanalysis 72, pt. 4 (1991): 639–656.

Anthony Bateman and Peter Fonagy, Mentalization-Based Treatment for Borderline Personality Disorder: A Practical Guide (Oxford, UK: Oxford University Press, 2006).

Anthony Bateman and Peter Fonagy, “8-Year Follow-Up of Patients Treated for Borderline Personality Disorder: Mentalization-Based Treatment Versus Treatment as Usual,” American Journal of Psychiatry 165 (2008): 631–638.

Otto F. Kernberg, Michael A. Selzer, Harold W. Koeningsberg, et al., Psychodynamic Psychotherapy of Borderline Patients (New York: Basic Books, 1989).

Frank E. Yeomans, John F. Clarkin, and Otto F. Kernberg, A Primer for Transference-Focused Psychotherapy for the Borderline Patient (Lanham, MD: Jason Aronson, 2002).

Robert J. Gregory and Anna L. Remen, “A Manual-Based Psychodynamic Therapy for Treatment-Resistant Borderline Personality Disorder,” Psychotherapy: Theory, Research, Practice, Training 45 (2008): 15–27.

Eric M. Plakun, “Making the Alliance and Taking the Transference in Work with Suicidal Borderline Patients,” Journal of Psychotherapy Practice and Research 10 (2001): 269–276.

Allan Abbass, Albert Sheldon, John Gyra, et al., “Intensive Short-Term Dynamic Psychotherapy for DSM-IV Personality Disorders: A Randomized Controlled Trial,” Journal of Nervous and Mental Disease 196 (2008): 211–216.

Antonio Menchaca, Orietta Perez, and Astrid Peralta, “Intermittent-Continuous Eclectic Therapy: A Group Approach for Borderline Personality Disorder,” Journal of Psychiatric Practice 13 (2007): 281–284.

John F. Clarkin, Kenneth N. Levy, Mark F. Lenzenweger, et al., “Evaluating Three Treatments for Borderline Personality Disorder: A Multiwave Study,” American Journal of Psychiatry 164 (2007): 922–928.

Josephine Giesen-Bloo, Richard van Dyck, Philip Spinhoven, et al., “Outpatient Psychotherapy for Borderline Personality Disorder: Randomized Trial of Schema-Focused Therapy vs. Transference-Focused Psychotherapy,” Archives of General Psychiatry 63 (2006): 649–658.

Antoinette D. I. van Asselt and Carmen D. Dirksen, “Outpatient Psychotherapy for Borderline Personality Disorder: Cost-Effectiveness of Schema-Focused Therapy vs. Transference-Focused Psychotherapy,” British Journal of Psychiatry 192 (2008): 450–457.

Ted Reichborn-Kjennerud, “Genetics of Personality Disorders,” Psychiatric Clinics of North America 31 (2008): 421–440.

Randy A. Sansone and Lori A. Sansone, “The Families of Borderline Patients: The Psychological Environment Revisited,” Psychiatry 6 (2009): 19–24.

Bernadette Grosjean and Guochuan E. Tsai, “NMDA Neurotransmission as a Critical Mediator of Borderline Personality Disorder,” Journal of Psychiatry and Neuroscience 32 (2007): 103–115.

Antonia S. New, Marianne Goodman, Joseph Triebwasser, et al., “Recent Advances in the Biological Study of Personality Disorders,” Psychiatric Clinics of North America 31 (2008): 441–461.

Bonnie Jean Steinberg, Robert L. Trestman, and Larry J. Siever, “The Cholinergic and Noradrenergic Neurotransmitter Systems and Affective Instability in Borderline Personality Disorder,” in Biological and Neurobehavioral Studies of Borderline Personality Disorder (Washington, DC: American Psychiatric Publishing, 2005): 41–62.

Mary C. Zanarini, Catherine R. Kimble, and Amy A. Williams, “Neurological Dysfunction in Borderline Patients and Axis II Control Subjects,” Biological and Neurobehavioral Studies of Borderline Personality Disorder (Washington, DC: American Psychiatric Publishing, 2005): 159–175.

Jose Manuel de la Funete, Julio Bobes, Coro Vizuete, et al., “Neurologic Soft Signs in Borderline Personality Disorder,” Journal of Clinical Psychiatry 67 (2006): 541–546.

Eric Lis, Brian Greenfield, Melissa Henry, et al., “Neuroimaging and Genetics of Borderline Personality Disorder: A Review,” Journal of Psychiatry and Neuroscience 32 (2007): 162–173.

American Psychiatric Association, “Practice Guideline for the Treatment of Patients with Borderline Personality Disorder,” American Journal of Psychiatry 158 (2001, October Supplement).

Mary C. Zanarini and Frances R. Frankenburg, “Omega-3 Fatty Acid Treatment of Women with Borderline Personality Disorder: A Double-Blind Placebo-Controlled Pilot Study,” American Journal of Psychiatry 160 (2003): 167–169.

Christopher Pittenger, John H. Krystal, and Vladimir Coric, “Initial Evidence of the Beneficial Effects of Glutamate-Modulating Agents in the Treatment of Self-Injurious Behavior Associated with Borderline Personality Disorder” (Letter to the Editor), Journal of Clinical Psychiatry 66 (2005): 1492–1493.

American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Revised , 3rd ed. (DSM-III-R) (Washington, DC: American Psychiatric Association, 1987): 16.

Michael H. Stone, The Fate of Borderline Patients: Successful Outcome and Psychiatric Practice (New York: Guilford, 1990).

Mary C. Zanarini, Frances R. Frankenburg, John Hennen, et al., “The McLean Study of Adult Development (MSAD): Overview and Implications of the First Six Years of Prospective Follow-Up,” Journal of Personality Disorders 19 (2005): 505–523.